Biological
ST266 clinical trials
Also written ST266.
- studies test it
- 12
- open now
- 1
- in phase 3
- 0
- first study started
- 2009
Keep track of what changes. Save the ST266 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
- ST266
- 10
Studies by the year they started
12 studies that test it; most in 2012 (2)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2012 | 2 |
| 2015 | 2 |
| 2016 | 2 |
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 6
- Phase 2
- 8
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 12 · Other 0
Noveome Biotherapeutics, formerly Stemnion (12)
Studies
Open first, then newest update. How each study uses ST266 is read from its arms, and is right about nine times in ten.
Testing it · 12
- Study to Assess the Safety, Tolerability, and Preliminary Efficacy of ST266 in Infants With Necrotizing Enterocolitis (NEC)RecruitingPhase 1/2Noveome Biotherapeutics, formerly StemnionNCT06315738Written as ST266
- Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo to Treat Allergic ConjunctivitisCompletedPhase 2Noveome Biotherapeutics, formerly StemnionNCT02978183Written as ST266
- ST266 Eyedrops for the Treatment of Persistent Corneal Epithelial DefectsTerminatedPhase 2Noveome Biotherapeutics, formerly StemnionNCT05066698Written as ST266
- Study of ST266 Given by Intranasal Delivery in Glaucoma Suspect SubjectsCompletedPhase 1Noveome Biotherapeutics, formerly StemnionNCT03901781Written as ST266 via Intranasal Delivery
- Safety and Tolerability Study of IV ST266 in COVID-19 SubjectsCompletedPhase 1Noveome Biotherapeutics, formerly StemnionNCT04720378Written as ST266
- ST266 Eye Drops for the Treatment of Persistent Corneal Epithelial DefectsCompletedPhase 2Noveome Biotherapeutics, formerly StemnionNCT03687632Written as ST266
- Safety, Efficacy and Treatment Regimen Study of ST266 in Subjects With Moderate to Severe PeriodontitisCompletedPhase 2Noveome Biotherapeutics, formerly StemnionNCT02761993Written as ST266
- ST266 in UV-induced InflammationCompletedPhase 2Noveome Biotherapeutics, formerly StemnionNCT02389777Written as ST266 immediate
- Study of ST266 in Diabetic Subjects With Deep Burns Managed With Skin GraftsTerminatedPhase 2Noveome Biotherapeutics, formerly StemnionNCT01715012Written as ST266
- ST266 Versus Standard Care In Treating Partial Thickness BurnsTerminatedPhase 1/2Noveome Biotherapeutics, formerly StemnionNCT00886470Written as ST266
- Study of ST266 Versus Saline in Treating Skin Irritation From RadiationCompletedPhase 1Noveome Biotherapeutics, formerly StemnionNCT01714973Written as ST266
- Study of ST266 Eye Drops in Treating Dry EyeCompletedPhase 1Noveome Biotherapeutics, formerly StemnionNCT02369861Written as ST266